How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Matthew Guay After a new round of testing, we found that the best app depends ...

Languages often co-express related meanings, either reusing words or combining parts of words. It is poorly understood when each strategy is favoured. Across 1,982 languages, Brochhagen et al. find ...